You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Baxter
Johnson and Johnson
Mallinckrodt
Harvard Business School

Last Updated: January 20, 2021

DrugPatentWatch Database Preview

Litigation Details for MERCK SHARP & DOHME CORP. v. APOTEX INC. (D.N.J. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

MERCK SHARP & DOHME CORP. v. APOTEX INC. (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-04-02
Court District Court, D. New Jersey Date Terminated 2018-02-02
Cause 35:271 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand Plaintiff Referred To Tonianne J. Bongiovanni
Parties APOTEX CORP.; APOTEX INC.; HON. GARRETT E. BROWN; MERCK SHARP & DOHME CORP.
Patents 6,127,353
Attorneys ARNOLD B. CALMANN; CHARLES H. CHEVALIER; CHRISTINE A. GADDIS; DAVID E. DELORENZI; ERIC EVANS WOHLFORTH , JR.; GARRETT E. BROWN , JR.; JAKOB BENJAMIN HALPERN; JEFFREY S. SOOS
Firms Jams
Link to Docket External link to docket
Small Molecule Drugs cited in MERCK SHARP & DOHME CORP. v. APOTEX INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for MERCK SHARP & DOHME CORP. v. APOTEX INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-12-20 110 of United States Patent No. 6,127,353 (the “’353 patent”). This action arises out of Defendants…AMENDED COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT …This is an action for patent infringement and for declaratory judgment of patent infringement of…of the ’353 patent. 50. Defendants have been on notice of the ’353 patent since at least…claim 1 of the ’353 patent. Defendants have had actual knowledge of the ’353 patent since at least as External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Express Scripts
Boehringer Ingelheim
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.